vs
BillionToOne, Inc.（BLLN）与MERCANTILE BANK CORP（MBWM）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是MERCANTILE BANK CORP的1.2倍（$83.5M vs $67.6M），MERCANTILE BANK CORP净利率更高（33.6% vs 6.8%，领先26.7%）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
BLLN vs MBWM — 直观对比
营收规模更大
BLLN
是对方的1.2倍
$67.6M
净利率更高
MBWM
高出26.7%
6.8%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $67.6M |
| 净利润 | $5.7M | $22.7M |
| 毛利率 | 69.9% | — |
| 营业利润率 | 11.5% | — |
| 净利率 | 6.8% | 33.6% |
| 营收同比 | 117.4% | — |
| 净利润同比 | 138.3% | 16.1% |
| 每股收益（稀释后） | $0.10 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNMBWM
| Q1 26 | — | $67.6M | ||
| Q4 25 | — | $62.1M | ||
| Q3 25 | $83.5M | $62.4M | ||
| Q2 25 | — | $60.9M | ||
| Q1 25 | — | $57.3M | ||
| Q4 24 | $45.1M | $58.5M | ||
| Q3 24 | $38.4M | $58.0M | ||
| Q2 24 | — | $56.8M |
净利润BLLNMBWM
| Q1 26 | — | $22.7M | ||
| Q4 25 | — | $22.8M | ||
| Q3 25 | $5.7M | $23.8M | ||
| Q2 25 | — | $22.6M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | $-11.5M | $19.6M | ||
| Q3 24 | $-14.9M | $19.6M | ||
| Q2 24 | — | $18.8M |
毛利率BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — |
营业利润率BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | 42.0% | ||
| Q3 25 | 11.5% | 44.0% | ||
| Q2 25 | — | 42.6% | ||
| Q1 25 | — | 42.0% | ||
| Q4 24 | 17.0% | 39.7% | ||
| Q3 24 | -32.9% | 42.4% | ||
| Q2 24 | — | 41.4% |
净利率BLLNMBWM
| Q1 26 | — | 33.6% | ||
| Q4 25 | — | 36.8% | ||
| Q3 25 | 6.8% | 38.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 34.1% | ||
| Q4 24 | -25.5% | 33.5% | ||
| Q3 24 | -38.8% | 33.8% | ||
| Q2 24 | — | 33.1% |
每股收益（稀释后）BLLNMBWM
| Q1 26 | — | $1.32 | ||
| Q4 25 | — | $1.41 | ||
| Q3 25 | $0.10 | $1.46 | ||
| Q2 25 | — | $1.39 | ||
| Q1 25 | — | $1.21 | ||
| Q4 24 | $-1.13 | $1.20 | ||
| Q3 24 | $-1.47 | $1.22 | ||
| Q2 24 | — | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | — |
| 总债务越低越好 | $55.0M | $1.5M |
| 股东权益账面价值 | $-239.5M | $736.9M |
| 总资产 | $327.5M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $191.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务BLLNMBWM
| Q1 26 | — | $1.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BLLNMBWM
| Q1 26 | — | $736.9M | ||
| Q4 25 | — | $724.9M | ||
| Q3 25 | $-239.5M | $657.6M | ||
| Q2 25 | — | $631.5M | ||
| Q1 25 | — | $608.3M | ||
| Q4 24 | $-251.7M | $584.5M | ||
| Q3 24 | $-242.9M | $583.3M | ||
| Q2 24 | — | $551.2M |
总资产BLLNMBWM
| Q1 26 | — | $6.9B | ||
| Q4 25 | — | $6.8B | ||
| Q3 25 | $327.5M | $6.3B | ||
| Q2 25 | — | $6.2B | ||
| Q1 25 | — | $6.1B | ||
| Q4 24 | $302.1M | $6.1B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.6B |
负债/权益比BLLNMBWM
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | — |
| 自由现金流经营现金流 - 资本支出 | $6.5M | — |
| 自由现金流率自由现金流/营收 | 7.7% | — |
| 资本支出强度资本支出/营收 | 8.8% | — |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | $18.0M | ||
| Q3 25 | $13.8M | $23.1M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $101.1M | ||
| Q3 24 | — | $-8.1M | ||
| Q2 24 | — | $9.1M |
自由现金流BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率BLLNMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | 0.79× | ||
| Q3 25 | 2.42× | 0.97× | ||
| Q2 25 | — | -0.35× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | — | 5.15× | ||
| Q3 24 | — | -0.41× | ||
| Q2 24 | — | 0.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
